Stem/progenitor cell populations for many types of cancer, including HCC, are thought to be enriched with cells that express CD44, a receptor for the stem cell growth factor, osteopontin [35], [36]. The gene discussed is CLEC11A; the disease is hepatocellular carcinoma.